Plastics: As Dangerous as Climate Change, But With a Solution
*By Conor White*
*For more information, visit National Geographic's Planet or Plastic campaign at [http://natgeo.com/planetorplastic](http://natgeo.com/planetorplastic).*
Decades of plastic consumption and the resulting waste has created a global accumulation of non-biodegradable materials that is choking the planet's waterways, as serious a problem as climate change, according to National Geographic. There is, however, one clear difference: Earth has an answer to its plastic problem.
By using silicone or metal straws, reusable water bottles, and canvas grocery bags instead of those made from plastic, consumers can ease the accumulation of plastic waste that's clogging the world's oceans, said Jenna Jambeck, a National Geographic explorer and associate professor at the University of Georgia.
"These sound really sort of mundane, but they're not," Jambeck said in an interview Monday with Cheddar. "They actually do make a difference, and people can choose the planet over plastic."
Each year, more than 9 million tons of plastic waste ends up in the ocean. According to some estimates, that plastic could remain in marine environments for 450 years or longer. National Geographic is hoping to reduce that number with its new ["Planet or Plastic?"](http://natgeo.com/planetorplastic) initiative, encouraging consumers to stop using single-use plastics.
"It can be empowering for people to know that actually, their choices do matter," Jambeck said. "Through this research, if you show that those individual actions that we take every day, taken collectively, or thinking about them over time, they definitely matter."
In 2015, Jambeck and a group of scientists calculated the amount of plastic waste finding its way into the planet's oceans annually, which became the impetus for the National Geographic initiative. It is featured in the June issue of National Geographic.
The 'Planet or Plastic?' initiative includes [tips](https://news.nationalgeographic.com/2018/05/plastics-facts-infographics-ocean-pollution) for consumers to reduce their use of plastics and a [pledge](https://www.nationalgeographic.com/environment/plasticpledge/?beta=true) to make a difference.
Jambeck said consumers should not to give up if they happen to forget their reusable water bottle or grocery bag.
"Be sort of forgiving with yourself, because every time that you remembered, you actually had an impact," she said.
For the full interview, [click here](https://cheddar.com/videos/national-geographic-launches-planet-or-plastic-initiative).
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
